"Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors and Migraine: Should Cochrane Close the Door?"
written by Daniel Shevel,
published by Journal of Biomedical Science and Engineering, Vol.11 No.4, 2018
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
No relevant information.